Fan, Zhongqi
ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics. [electronic resource]
- Experimental cell research Jul 2015
- 68-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1090-2422
Standard No.: 10.1016/j.yexcr.2015.04.016 doi
Subjects--Topical Terms: Antineoplastic Combined Chemotherapy Protocols--administration & dosage Apoptosis--drug effects Bile Duct Neoplasms--drug therapy Bile Ducts, Intrahepatic Biphenyl Compounds--administration & dosage Cell Line Cell Survival--drug effects Cholangiocarcinoma--drug therapy Cisplatin--administration & dosage Drug Resistance, Neoplasm--drug effects Dynamins GTP Phosphohydrolases--metabolism Humans Membrane Proteins--metabolism Membrane Transport Proteins--metabolism Microtubule-Associated Proteins--metabolism Mitochondria--metabolism Mitochondrial Dynamics--drug effects Mitochondrial Precursor Protein Import Complex Proteins Mitochondrial Proteins--metabolism Mitophagy--drug effects Myeloid Cell Leukemia Sequence 1 Protein--biosynthesis Nitrophenols--administration & dosage Piperazines--administration & dosage Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors RNA Interference RNA, Small Interfering--genetics RNA-Binding Proteins--genetics Receptors, Cell Surface--metabolism Sulfonamides--administration & dosage bcl-2 Homologous Antagonist-Killer Protein--biosynthesis